Boothbay Fund Management, LLC Iovance Biotherapeutics, Inc. Transaction History

Boothbay Fund Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$12.38 - $19.1 $214,991 - $331,690	-17,366 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$16.55 - $27.63 $96,122 - $160,475	-5,808 Reduced 25.06%	17,366 $332,000
Q3 2021 Nov 15, 2021	SELL	$20.35 - $26.63 $12,148 - $15,898	-597 Reduced 2.51%	23,174 $571,000
Q2 2021 Aug 16, 2021	BUY	$16.33 - $33.07 $388,180 - $786,106	23,771 New	23,771 $619,000

313

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.28B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.